Milpitas, California-based Applied StemCell Inc, a gene-editing company, has raised $19 million in Series D funding. HerMed Capital led the round with participation from other investors that included Ping An Ventures, Vi-Ventures and BioSciKin.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: